Skip to main content
Erschienen in: Reactions Weekly 1/2021

01.10.2021 | Clinical study

Vesicular or bullous cutaneous eruption following zoster vaccination

Erschienen in: Reactions Weekly | Ausgabe 1/2021

Einloggen, um Zugang zu erhalten

Excerpt

Analysing spontaneous reports of blister-like skin rashes following vaccination with an adjuvanted recombinant zoster vaccine [RZV; Shingrix; GSK] did not raise safety concerns about the occurrence of vesicular or cutaneous bullous eruptions, according to study results reported in Drug Safety. …
Literatur
Zurück zum Zitat Pirrotta P, et al. An Analysis of Spontaneously Reported Data of Vesicular and Bullous Cutaneous Eruptions Occurring Following Vaccination with the Adjuvanted Recombinant Zoster Vaccine. Drug Safety : 7 Oct 2021. Available from: URL: http://doi.org/10.1007/s40264-021-01118-3 Pirrotta P, et al. An Analysis of Spontaneously Reported Data of Vesicular and Bullous Cutaneous Eruptions Occurring Following Vaccination with the Adjuvanted Recombinant Zoster Vaccine. Drug Safety : 7 Oct 2021. Available from: URL: http://​doi.​org/​10.​1007/​s40264-021-01118-3
Metadaten
Titel
Vesicular or bullous cutaneous eruption following zoster vaccination
Publikationsdatum
01.10.2021
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2021
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-021-03982-0

Weitere Artikel der Ausgabe 1/2021

Reactions Weekly 1/2021 Zur Ausgabe

Case report

Multiple drugs

Case report

Levilimab

Case report

Simvastatin

Case report

Levodopa